Regulation & law · 03/05/2007
DEA Places Lisdexamfetamine in Schedule II of Controlled Substances Act
The Drug Enforcement Administration has finalized a rule placing lisdexamfetamine, a stimulant medication, under the same regulatory controls as other Schedule II substances, affecting its manufacture, distribution, and use.
Original source language: Federal Register — Justice DepartmentOpen original release →